Weiwei Yu
Impact in
- Immunology top 5%
- Immune Cell Function and Interaction
- Immune cells in cancer
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
- Immunology 14
- Immune Cell Function and Interaction 5
- Immunotherapy and Immune Responses 4
-
- MicroRNA in disease regulation 4
- Cancer-related molecular mechanisms research 4
- Co-authors
- Zhexu ChiDanlu JiangKailian ZhangTing XuSheng ChenAnh D. LeAndrew L. NguyenQifeng He
- Journals
- Biomedical Chromatography (2 papers)Oncotarget (2 papers)Cellular and Molecular Immunology (2 papers)Molecular Cell (2 papers)Immunity (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Weiwei Yu
47 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 116
- Immunology 477
- Cancer Research 315
- Molecular Biology 937
- Oncology 338
- Urology 77
Countries citing papers authored by Weiwei Yu
This map shows the geographic impact of Weiwei Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Yu more than expected).
Fields of papers citing papers by Weiwei Yu
This network shows the impact of papers produced by Weiwei Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Yu. The network helps show where Weiwei Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Weiwei Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 14 | |
| 3 | 2023 | 4 | |
| 4 | 2023 | 7 | |
| 5 | 2023 | 3 | |
| 6 | 2022 | 86 | |
| 7 | 2022 | 15 | |
| 8 | 2021 | 1 | |
| 9 | 2020 | 101 | |
| 10 | 2019 | 213 | |
| 11 | 2019 | 250 | |
| 12 | 2018 | 1 | |
| 13 | 2017 | 15 | |
| 14 | 2017 | 15 | |
| 15 | 2017 | 40 | |
| 16 | 2017 | 27 | |
| 17 | 2017 | 24 | |
| 18 | 2016 | 19 | |
| 19 | 2015 | 5 | |
| 20 | 2009 | 40 |
About Weiwei Yu
Weiwei Yu is a scholar working on Immunology, Cancer Research, Oncology, Molecular Biology and Microbiology, having authored 49 papers that have together received 1.8k indexed citations. Recurring topics across this work include Inflammasome and immune disorders (6 papers), Immune Cell Function and Interaction (5 papers), MicroRNA in disease regulation (4 papers), Immunotherapy and Immune Responses (4 papers), Cancer-related molecular mechanisms research (4 papers), CAR-T cell therapy research (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Circular RNAs in diseases (4 papers). The work is most often cited by research in Immunology (477 citations), Cancer Research (315 citations), Molecular Biology (937 citations), Oncology (338 citations) and Urology (77 citations). Weiwei Yu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Zhexu Chi, Danlu Jiang, Kailian Zhang, Ting Xu, Sheng Chen, Anh D. Le, Andrew L. Nguyen, Qifeng He, Wenfang Tian and Beicheng Sun. Their work appears in journals such as Biomedical Chromatography, Oncotarget, Cellular and Molecular Immunology, Molecular Cell and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.